Latest Presentation
Recent Event
2021 Annual Meeting of Shareholders
Latest Financial Results
Q1 2021
Quarter Ended Mar 31, 2021
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2020
Report Links
Company Overview
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders.
IR Contacts
Company
Natus Medical Incorporated
6701 Koll Center Parkway
Suite 120
Pleasanton, CA 94566
T: 800-645-3616
F: 650-802-0401
Investor Relations
Natus Medical Incorporated
Drew Davies
Chief Financial Officer
T: (925) 223-6700
InvestorRelations@Natus.com
Transfer Agent
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
T: (877) 830-4936
https://www.shareholder.broadridge.com